| |
 |
Peter T Bartels AO, FAISM, FRS
Chairman and Non-executive Director
Mr Bartels has experience in the pharmaceutical industry through previous roles with DHA Pharmaceuticals and Abbott Laboratories. He has been a major player in corporate Australia, having held the positions of CEO and Managing Director of both Coles Myer Ltd and Fosters Brewing Company Ltd. He is a past Chairman of the Australian Sports Commission, the Australian Institute of Sport, the Commonwealth Heads of Government Committee for Sport and the Women’s and Children’s Health Service. |
 |
John Raff, Dip Ag Sc, BSc, PhD
Deputy Chairman and Non-executive Director
Dr Raff was Starpharma’s Chief Executive Officer from the Company’s founding until July 2006. Previously, Dr Raff was General Manager of the Biomolecular Research Institute. He received a PhD from Melbourne University in 1982 for molecular biology studies on cell recognition systems, under the supervision of Professor Adrienne Clarke. Dr Raff is the co-founder, director and major shareholder of a technology-based agricultural seed company, and is also founder and investor in a number of start-up technology companies. He is Chairman of the BioMelbourne Network. |
 |
Jackie Fairley, BSc, BVSc (Hons), MBA
Chief Executive Officer
Dr Fairley was appointed Chief Executive Officer of Starpharma on 1 July 2006 after serving in the role of Chief Operating Officer from July 2005. As CEO and a Director of the Board, Jackie’s responsibilities include involvement in setting strategic direction, oversight of operations and financing activities for the group. She also plays an active role in driving key commercial negotiations and development programs and corporate activity. Jackie has more than 20 years’ experience in the pharmaceutical and biotechnology industries working in business development and senior management roles with companies including CSL and Faulding (now Hospira). Former CEO of Cerylid Biosciences, Jackie also spent 5 years as Vice President for Faulding’s injectable division and 5 years with CSL in various executive roles. She holds first class honours degrees in Science (pharmacology/pathology) and Veterinary Science, and has an MBA from the Melbourne Business School where she was the recipient of the Clemenger Medal. |
 |
Ross Dobinson, BBus (Acc)
Non-executive Director
Mr Dobinson is a merchant banker with a background in investment banking and stockbroking. He has acted as Corporate Director for two leading stockbrokers, and was Executive Director of the NAB’s corporate advisory subsidiary. He later headed the corporate advisory division of Dresdner Australia Ltd. Mr Dobinson is currently Managing Director of TSL Group Ltd, a corporate advisory company specialising in establishing and advising life science companies. He is Chairman of listed company Acrux Ltd, and is also a Director of a number of unlisted companies. |
 |
Richard A Hazleton, BSChE, MSChE, HonDrEngr, HonDrCommSci
Non-executive Director
Mr Hazleton is retired Chairman and CEO of Dow Corning Corporation. He joined Dow Corning in 1965 and held numerous positions in engineering, manufacturing and finance, both in the US and Europe, before becoming CEO of the company in 1993, and Chairman of the Board of Directors and CEO in 1994. He retired from Dow Corning in 2001. He served as Chairman of Dendritic Nanotechnologies Inc (DNT) from 2004 until Starpharma’s acquisition of the company in October 2006. Mr Hazleton has served on the Boards of the American Chemistry Council and the Chemical Bank and Trust Company (Midland, MI, USA) as well as several non-profit social service agencies in Michigan and Belgium. |
 |
Peter J Jenkins, MB, BS (Melb), FRACP
Non-executive Director
Dr Jenkins is a consultant physician and gastroenterologist who holds clinical and research positions with the Alfred Hospital, and has held clinical research positions with the Baker Medical Research Centre. He is a former judge of the Australian Technology Awards and is Executive Director of AusBio Ltd, an unlisted public biotechnology company. |
|
 |
|
